Photocure ASA: Annual Report 2023

The documents are enclosed and also made available at the company's website under https://photocure.com/investors-hub/investors-events-and-presentations. The documents are enclosed and also made available at the company's website underhttps://photocure.com/investors-hub/investors-events-and-presentations. For further information, please contact: Photocure CFOErik DahlTel: +47 450 55 000 Email:ed@photocure.com About Photocure ASA: Photocure: The Bladder Cancer Company...

The documents are enclosed and also made available at the company's website under https://photocure.com/investors-hub/investors-events-and-presentations.

For further information, please contact:
Photocure
CFO Erik Dahl
Tel: +47 450 55 000
Email: ed@photocure.com

About Photocure ASA:

Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com or www.cysview.com.

All trademarks mentioned in this release are protected by law and are registered trademarks of Photocure ASA. This information is subject to the disclosure requirements pursuant to sections 5-12 of the Norwegian Securities Trading Act.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/photocure/r/photocure-asa--annual-report-2023,c3970681

The following files are available for download:

 

View original content:https://www.prnewswire.co.uk/news-releases/photocure-asa-annual-report-2023-302131417.html